Dr. Yang Sun 孙阳
Chief Physician
Department of Gynecologic Oncology, Fujian Cancer Hospital, Fuzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical, laparoscopic minimally invasive, and comprehensive treatment of benign and malignant gynecologic tumors, including ovarian tumors, endometrial cancer, cervical cancer, and endometriosis.
Dr. Sun holds an MD and serves as Deputy Director of Fujian Cancer Hospital. After earning a bachelor’s degree from Southeast University in 1999 and a master’s in 2002, Dr. Sun worked at Fujian Provincial Hospital. A doctoral degree was obtained from Sichuan University West China Medical Center in 2010. Dr. Sun completed a one-year visiting fellowship at Mayo Clinic in 2016 and joined Fujian Cancer Hospital in January 2020.
Professional roles
- Vice Chair, Gynecologic Oncology Branch, Fujian Medical Association
- Vice Chair, Gynecologic Oncology Committee, Fujian Anti-Cancer Association
- Standing Committee Member, Gynecology and Obstetrics Branch, Fujian Medical Association
- Member, Gynecologic Endoscopy Quality Control Center, Fujian Medical Association
Name order: in Chinese the family name comes first (Sun Yang). Papers usually list the name as Yang Sun or Sun Y.
Selected publications
100 papers on PubMed matched by name and affiliation; 75 as first or senior author since 2016. Most recent first- or senior-author papers:
- Curr Oncol, 2026 (senior author): MRI-Based Radiomics Model for Pretreatment Prediction of Pathological Lymph Node Metastasis in Neuroendocrine Carcinoma of the Cervix: Dual-Center Development and External Validation. PubMed 42930192
- Front Immunol, 2026 (senior author): Multidisciplinary treatment incorporating autologous DC-CIK cell therapy induces long-term survival in advanced pancreatic cancer: a case report. PubMed 42827491
- Chin Med J (Engl), 2026 (senior author): Oncogenic DNMT3B as a therapeutic target for cervical cancer. PubMed 42402721
- BMC Womens Health, 2026 (senior author): Temporal patterns of serial intraoperative peritoneal cytology among patients undergoing cup-assisted surgery for endometrial cancer: a single-center observational process-monitoring study. PubMed 42977974
- J Transl Med, 2026 (senior author): Cross-layer multiomic and digital pathology analysis identifies a malignant keratinization state linked to immune exclusion in cervical squamous carcinoma. PubMed 42426811
- Acta Biomater, 2026 (senior author): Exploring the interactions between nanoparticles and biological organisms using advanced imaging and omics technologies. PubMed 42173461
- J Gynecol Oncol, 2026 (senior author): Neoadjuvant therapy of iparomlimab and tuvonralimab combined with chemotherapy-extenuated for locally advanced cervical cancer (NICE-CC): an investigator-initiated, multicentre, open-label, phase II trial. PubMed 41775252
- Am J Obstet Gynecol, 2026 (senior author): Prognostic role of immunohistochemical and molecular markers in no specific molecular profile endometrial cancer (letter to the editor). PubMed 41548633
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion